Physician profile
Ambreen Ashfaque
NPI 1063611358
$3,026.22
in general payments reported to CMS, 2019-2025
28 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $158 · 2021: $650 · 2022: $935 · 2023: $291 · 2024: $398 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $770.46 | 2021-2025 | Verquvo, Capvaxive |
| Baxter Healthcare | $388.80 | 2022 | |
| Endologix LLC | $272.89 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $260.36 | 2019-2024 | |
| Tactile Systems Technology INC | $210.42 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Amgen INC. | $187.03 | 2019-2021 | |
| Astellas Pharma US INC | $140.01 | 2019-2021 | |
| Amarin Pharma, INC. | $135.49 | 2019-2022 | |
| Bolton Medical INC | $128.96 | 2024 | Treo Abdominal Stent-Graft System |
| Esperion Therapeutics, INC. | $76.56 | 2020-2021 | |
| Cagent Vascular INC | $64.48 | 2024 | Serrantor |
| Cardiovascular Systems INC. | $50.63 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $50.30 | 2019-2020 | |
| Novo Nordisk INC | $40.58 | 2022-2024 | Ozempic |
| Boston Scientific Corporation | $33.69 | 2021-2023 | Varithena Administration Pack |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.31 | 2022 | |
| Bardy Diagnostics, INC. | $20.56 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $19.89 | 2022 | |
| Medtronic Vascular, INC. | $18.32 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.48 | 2019 | |
| Integra Lifesciences Corporation | $16.47 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Vesper Medical | $15.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.14 | 2021 | |
| Medicomp INC | $15.12 | 2021 | |
| Angiodynamics, INC. | $13.62 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.94 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.77 | 2019 | |
| Medicure Pharma INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ambreen Ashfaque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.